Saturday 17 October 2026
Export ANIX’s income statement to Excel — free account
ANIXA BIOSCIENCES INC
ANIX Healthcare Biotechnology
ANIXA BIOSCIENCES INC’s revenue for fiscal 2023 (year ended October 2023) was $210,000.00. In the quarter to July 2026, EPS fell 14.3% and free cash flow fell 17.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.67
0.11
−3.96%
Follow ANIX
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
7.95 | 9.16 | 11.49 | 7.71 | |
Current Ratio |
8.55 | 9.79 | 12.18 | 8.08 | |
Net Debt/EBITDA |
5.06 | 5.24 | 5.34 | 5.20 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 0.69 | 1.02 | 0.47 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.05) | (0.05) | (0.08) | (0.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.05) | (0.05) | (0.08) | (0.04) | |
Cash per Share |
0.41 | 0.41 | 0.43 | 0.47 | |
Shareholders Equity per Share |
0.39 | 0.39 | 0.42 | 0.43 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.39 | 0.39 | 0.42 | 0.43 | |
Free Cash Flow |
(1.77) | (1.74) | (2.61) | (1.25) | |
Working Capital |
13.17 | 13.19 | 13.81 | 13.92 | |
Net Current Asset Value |
13.04 | 13.05 | 13.66 | 13.76 | |
| Other line items | |||||
Average Receivables |
— | 0.22 | — | — | |
Average Payables |
0.28 | 0.27 | 0.37 | 0.35 | |
Average Assets |
16.36 | 15.92 | 17.07 | 18.84 | |
Average Common Equity |
14.31 | 14.07 | 15.28 | 16.42 |
Columns are period end dates